• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
TAMIFLU Product Monograph
TAMIFLU Product Monograph

... Efficacy of TAMIFLU in the treatment of subjects with chronic cardiac disease and/or respiratory disease has not been established. No difference in the incidence of complications was observed between the treatment and placebo groups in this population. No information is available regarding treatment ...
ZYRTEC-D 12 HOUR   (cetirizine hydrochloride 5 mg and
ZYRTEC-D 12 HOUR  (cetirizine hydrochloride 5 mg and

... Extended Release Tablets with alcohol or other CNS depressants should be avoided because additional reductions in alertness and additional impairment of CNS performance may occur. Drug Interactions: Cetirizine hydrochloride and pseudoephedrine hydrochloride do not influence the pharmacokinetics of e ...
A Comprehensive Strategy for Host Cell Protein Analysis in
A Comprehensive Strategy for Host Cell Protein Analysis in

... provides an in depth discussion of the manifestations of lack of antibody excess under the topics of “poor dilutional linearity” and “hook affect”. To summarize those discussions, ELISA is only quantitative when it has an excess of both capture and detector antibody for the antigen being detected. I ...
Genome-wide analysis by SNP Array
Genome-wide analysis by SNP Array

... diagnosis of the micro-rearrangements involved in ID and CA. Low karyotyping resolution (5-10 Mb) and the targeted analysis of FISH represent a significant restriction for ID and CA diagnosis. However, DNA microarrays have proved their utility in the diagnosis of ID and CA. They detect genomic disor ...
Symposium Report Correlating Structure and Function of Drug
Symposium Report Correlating Structure and Function of Drug

... on the P450 and to probe P450 conformational dynamics. Early studies illustrate part of this potential, having probed the interactions of b5 with human CYP17A1 (Estrada et al., 2013) and with CYP2B4 (Ahuja et al., 2013), confirming residues involved in the interface and revealing that ligands in the ...
Effects of rimonabant on body weight, glucose control
Effects of rimonabant on body weight, glucose control

... the therapeutic CB1 modulation deserves much attention in the management of metabolic disorders associated with abdominal obesity in order to reduce the so-called cardiometabolic risk [20-24]. The aim of the present review is to analyze the currently available human data from randomised controlled t ...
Seizures
Seizures

... 6)Serum anticonvulsant levels: □It should be used only as a guide to management, ...
Naloxone - Idaho Society of Health
Naloxone - Idaho Society of Health

... • Anyone that has a prescription for opioids • Anyone with a history of opioid or heroin abuse • Family/friends of someone prescribed opioids, that has access to opioids or uses heroin • Those who are recently released from incarceration or who were abstinent • Programs and residential facilities th ...
VIOXX® - Merck.com
VIOXX® - Merck.com

... VIOXX has demonstrated significant reduction of joint tenderness/pain and joint swelling compared to placebo. VIOXX was evaluated for the treatment of the signs and symptoms of RA in two 12-week placebo- and active-controlled clinical trials that enrolled a total of approximately 2,000 patients. VIO ...
The relationship between methamphetamine use and violent
The relationship between methamphetamine use and violent

... The current bulletin assesses whether there is any relationship between the increasing assault rate in NSW seen over the past decade and increasing methamphetamine use. During this time, there have been several changes to methamphetamine use patterns that could have contributed to an increase in met ...
Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice
Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice

... According to both in vitro and in vivo data P-glycoprotein (P-gp) may restrict the uptake of several antidepressants into the brain, thus contributing to the poor success rate of current antidepressant therapies. The therapeutic activity of citalopram resides in the S-enantiomer, whereas the R-enant ...
- International Journal of Advanced Biological and
- International Journal of Advanced Biological and

... Methenamine salts are therapeutic agents and have bactericidal effect. Most gram-positive and gramnegative pathogens are susceptible (Sweetman et al. 2009; Ahrens and Martin 2013; Al-Badr and AlShaikh 2013; Hickling and Nitti 2013). In many countries such as, United States, Austria, Polish, Canada, ...
Adherence to the NASPE guideline for amiodarone monitoring
Adherence to the NASPE guideline for amiodarone monitoring

... obtaining baseline parameter measurements within their health system and likely influences the sense of responsibility they and other providers feel for ensuring appropriate follow-up monitoring. However, the magnitude and clinical importance of these influences are not known. Currently, there are n ...
Thalidomide in Children Undergoing Bone Marrow Transplantation: Series at a
Thalidomide in Children Undergoing Bone Marrow Transplantation: Series at a

... Series at a Single Institution and Review of the Literature ABSTRACT. Thalidomide has one of the most notorious drug histories because of its teratogenicity. Its widespread use in the 1960s led to a worldwide epidemic of phocomelia in inborns; this in turn led to its complete ban in most of the worl ...
Vancomycin Injection, USPFor Intravenous Use Only
Vancomycin Injection, USPFor Intravenous Use Only

pi_azactam_injection - Products - Bristol
pi_azactam_injection - Products - Bristol

... Diameters (mm) ...
Colchicine for Prevention of Postoperative Atrial Fibrillation:
Colchicine for Prevention of Postoperative Atrial Fibrillation:

... c. Clinical trials for pericarditis reduced side effects by avoiding loading dose and using weight-based dosing 2. Case reports suggest colchicine may delay ocular wound healing a. No reports that colchicine affects wound healing in other types of surgeries iv. Metabolism, contraindications, drug in ...
abiraterone acetate - Therapeutic Goods Administration
abiraterone acetate - Therapeutic Goods Administration

... bone scan to document progression. Analysis of rPFS utilized centrally-reviewed radiographic assessment of progression. At the planned rPFS analysis there were 401 radiographic progression events; 150 (28%) of patients treated with abiraterone and 251 (46%) of patients treated with placebo had radio ...
MDMA powder
MDMA powder

... intimate communication with their significant others. In a subsequent publication on the treatment method, the authors reported one patient with severe pain from terminal cancer experienced lasting pain relief and improved quality of life.[15] In the United States, no research on MDMA was allowed at ...
Genetic analysis of non-syndromic craniosynostosis
Genetic analysis of non-syndromic craniosynostosis

... Accepted 11 March 2007 To cite this article: Boyadjiev SA: Genetic analysis of non-syndromic craniosynostosis Orthod Craniofacial Res 10, 2007; 129–137 Copyright  2007 The Author. Journal compilation  2007 Blackwell Munksgaard ...
advanced sedation techniques
advanced sedation techniques

... remember that these patients are done under conscious sedation and that any manipulation of the mouth or airway, the use of dental equipment or aids, like the rubber dam, still has to be done in a careful and gentle way, so as not to disturb the patient’s level of consciousness. ...
Reyataz ® (atazanavir) - Bristol
Reyataz ® (atazanavir) - Bristol

... Geriatrics (> 65 years of age) Clinical studies of REYATAZ did not include sufficient numbers of patients aged 65 and over to determine whether they respond differently from younger patients. In general, dose selection for an elderly patient should reflect the greater frequency of decreased hepatic, ...
DEVELOPMENT AND VALIDATION OF UV SPECTROSCOPIC METHOD FOR DETERMINATION
DEVELOPMENT AND VALIDATION OF UV SPECTROSCOPIC METHOD FOR DETERMINATION

... is formulating as 1:1 sulphate salt. The drug was approved by USFDA on June 20, 2003. Literature survey revealed that Atazanavir was quantitatively assayed in biological fluids either individually1 or in presence of other retroviral drugs using liquid chromatography2,3, Estimation of Atazanavir in b ...
JUL -9 2235 ‘Y?
JUL -9 2235 ‘Y?

... mg/kg/day for 2-2.5 years without side effects. These individual were all children under 10 years of age. Tolerance of these doses was in excess of the tolerated dose of 6 mg per kg reported by Rosen in adults (See Appendix 2 in the Additional Safety Information submitted May 18, 1998) B. DIM supple ...
ASCO 2011 NKTR-102 PopPK Poster
ASCO 2011 NKTR-102 PopPK Poster

... first-order appearance rates consistent with their metabolic progression (Tmax 1.5-24 hr) and first-order terminal t1/2 between 21-61 days. PK of NKTR-102 and all metabolites were independent of dose and schedule. BSA was a significant covariate for CL. SN38 CL was lower (30%) in females and lower ( ...
< 1 ... 77 78 79 80 81 82 83 84 85 ... 1254 >

Pharmacogenomics

Pharmacogenomics (a portmanteau of pharmacology and genomics) is the study of the role of genetics in drug response. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Through the utilization of pharmacogenomics, it is hoped that drug treatments can deviate from what is dubbed as the “one-dose-fits-all” approach. It attempts to eliminate the trial-and-error method of prescribing, allowing physicians to take into consideration their patient’s genes, the functionality of these genes, and how this may affect the efficacy of the patient’s current and/or future treatments (and where applicable, provide an explanation for the failure of past treatments). Such approaches promise the advent of ""personalized medicine""; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. Whether used to explain a patient’s response or lack thereof to a treatment, or act as a predictive tool, it hopes to achieve better treatment outcomes, greater efficacy, minimization of the occurrence of drug toxicities and adverse drug reactions (ADRs). For patients who have lack of therapeutic response to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic-based recommendations for a given drug, two possible types of input can be used: genotyping or exome or whole genome sequencing. Sequencing provides many more data points, including detection of mutations that prematurely terminate the synthesized protein (early stop codon).
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report